https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/accounts-receivable-net https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/accrued-salaries-current https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/acquisitions https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/capitalized-computer-software-gross https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/contracts-revenue https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/debt-increase-additional-borrowings https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/debt-issued https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/debt-repaid https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance-current https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance-noncurrent https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-goodwill https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/dilutive-shares https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/direct-operating-costs https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/discontinued-operation-gain-loss-on-disposal-of-discontinued-operation-net-of-tax https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/due-to-related-parties-current https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/due-to-related-parties-noncurrent https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/excess-tax-benefit-from-share-based-compensation-financing-activities https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/furniture-and-fixtures-gross https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/gain-loss-on-sale-of-other-assets https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/goodwill https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/goodwill-change https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/goodwill-impaired-accumulated-impairment-loss https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/income-loss-from https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/increase-decrease-in-other-deferred-liability https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/increase-decrease-in-restricted-cash-and-investments https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/insider-transactions-other https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/interest-costs-incurred https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/interest-expense-on-debt https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/interest-payable-current https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/licenses-revenue https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/line-of-credit-facility-commitment-fee-percentage https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/loans-payable-to-bank-current https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/long-term-debt https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/long-term-debt-percentage-bearing-fixed-interest-rate https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/long-term-loans-from-bank https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/number-of-reportable-segments https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/other-current-assets https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/other-depreciation-and-amortization https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/other-employee-related-liabilities-current https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/payments-to-acquire-restricted-investments https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/prepaid-expense-current https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/proceeds-from-contributions-from-parent https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/proceeds-from-divestiture-of-businesses https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/proceeds-from-issuance-of-secured-debt https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/proceeds-from-sale-of-restricted-investments https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/reimbursement-revenue https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/restricted-cash-and-investments-noncurrent https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/revenue-recognition-milestone-method-revenue-recognized https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/royalty-revenue https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-award-non-option-equity-instruments-granted https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-option-plan-expense https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/stock-options-vested-in-period-fair-value-1 https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/furiex-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted